A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders.

Fourier, A; Formaglio, M; Kaczorowski, F; Mollion, H; Perret-Liaudet, A; Sauvee, M; Quadrio, I

Fourier, A; Formaglio, M; Kaczorowski, F; Mollion, H; Perret-Liaudet, A; Sauvee, M; Quadrio, I.

Affiliation

Fourier A; Biochemistry Department, Lyon University Hospital, Lyon, France.
Formaglio M; Lyon Neuroscience Research Center BIORAN Team - CNRS UMR 5292, INSERM U1028, Université de Lyon, Lyon, France.
Kaczorowski F; Neurocognition and Neuro-ophthalmology Department, Lyon University Hospital, Lyon, France.
Mollion H; Centre Mémoire de Ressources et de Recherche de Lyon, Lyon, France.
Perret-Liaudet A; Biochemistry Department, Lyon University Hospital, Lyon, France.
Sauvee M; Lyon Neuroscience Research Center BIORAN Team - CNRS UMR 5292, INSERM U1028, Université de Lyon, Lyon, France.
Quadrio I; Centre Mémoire de Ressources et de Recherche de Lyon, Lyon, France.

Eur J Neurol ; 27(7): 1164-1169, 2020 07.

Article in En | MEDLINE | ID: mdl-32243670

Subject(s)

Intermediate Filaments; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Humans; Neurofilament Proteins; Retrospective Studies; tau Proteins

Key words

CSF AD biomarkers; CSF neurofilament; dementia; differential diagnosis; neurodegenerative disorders; primary psychiatric disorders

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Intermediate Filaments Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2020 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google